Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Drug Design, Development and Therapy|May 30, 2014
Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesionsAndreas O Doesch, Li Zhao, Christian A Gleissner, et al.
Atherosclerosis|April 9, 2017
Galectin-3 binding protein, coronary artery disease and cardiovascular mortality: Insights from the LURIC studyChristian A Gleissner, Christian Erbel, Fabian Linden, et al.
Drug Design, Development and Therapy|March 12, 2015
Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantationMatthias Helmschrott, Rasmus Rivinius, Arjang Ruhparwar, et al.
Plos One|November 3, 2015
CXCL4 Plasma Levels Are Not Associated with the Extent of Coronary Artery Disease or with Coronary Plaque MorphologyChristian Erbel, Grigorios Korosoglou, Pearlyn Ler, et al.
Drug Design, Development and Therapy|September 24, 2014
Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimenMatthias Helmschrott, Jan Beckendorf, Ceylan Akyol, et al.
Frontiers in Cardiovascular Medicine|March 31, 2022
Identification of Specific Coronary Artery Disease Phenotypes Implicating Differential PathophysiologiesJona B Krohn, Y Nhi Nguyen, Mohammadreza Akhavanpoor, et al.
Scientific Reports|July 14, 2018
Systematic RNA-interference in primary human monocyte-derived macrophages: A high-throughput platform to study foam cell formationGabriele Domschke, Fabian Linden, Lukas Pawig, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 9, 2014
Low levels of natural IgM antibodies against phosphorylcholine are independently associated with vascular remodeling in patients with coronary artery diseaseChristian A Gleissner, Christian Erbel, Julia Haeussler, et al.
Drug Design, Development and Therapy|January 2, 2015
Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapyRasmus Rivinius, Matthias Helmschrott, Arjang Ruhparwar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 28, 2014
IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosisChristian Erbel, Mohammadreza Akhavanpoor, Deniz Okuyucu, et al.
Pageof 3